HLA-DQA1 and PLA2R1 polymorphisms and risk of idiopathic membranous nephropathy.
about
Genetic and epigenetic factors influencing chronic kidney diseaseInsights into kidney diseases from genome-wide association studies.Anti-Phospholipase A2 Receptor Antibody Titer Predicts Post-Rituximab Outcome of Membranous NephropathyImmunopathogenesis of membranous nephropathy: an update.Variants in the Promoter Region of HLA-DQA1 were Associated with Idiopathic Membranous Nephropathy in a Chinese Han Population.Novel Biomarkers for Renal Diseases? None for the Moment (but One).Renal Phospholipase A2 Receptor and the Clinical Features of Idiopathic Membranous Nephropathy.Genetics of childhood steroid-sensitive nephrotic syndrome.PLA2R and THSD7A: Disparate Paths to the Same Disease?Genetic risk variants for membranous nephropathy: extension of and association with other chronic kidney disease aetiologies.Efficacy and safety of tacrolimus vs. cyclophosphamide for idiopathic membranous nephropathy: A meta-analysis of Chinese adults.Recent Progress in Deciphering the Etiopathogenesis of Primary Membranous Nephropathy.High-density Association Mapping and Interaction Analysis of PLA2R1 and HLA Regions with Idiopathic Membranous Nephropathy in Japanese.Anti-phospholipase A2 Receptor Antibody and Immunosuppression in Membranous Nephropathy: More Evidence for Pathogenicity of Anti-phospholipase A2 Receptor Autoantibodies.Analysis of PLA2R1 and HLA-DQA1 sequence variants in Japanese patients with idiopathic and secondary membranous nephropathy.Genetics of membranous nephropathy.Urine anti-PLA2R antibody is a novel biomarker of idiopathic membranous nephropathy.Lessons from CKD-Related Genetic Association Studies-Moving Forward.Membranous Nephropathy and Anti-Podocytes Antibodies: Implications for the Diagnostic Workup and Disease Management.Genetic Complexities of the HLA Region and Idiopathic Membranous Nephropathy.Identification of a two-SNP PLA2R1 Haplotype and HLA-DRB1 Alleles as Primary Risk Associations in Idiopathic Membranous Nephropathy
P2860
Q27024548-6BE37539-8E52-4AB8-AE26-06DE9A91B56AQ30248678-27ECA934-E0DE-415C-BA5E-D73E80AB1A30Q36104805-6F4A362F-763D-4C7B-8BB4-925325A6C79BQ38203172-9395BC76-9AA4-4E33-A628-64ED375E2A54Q38689851-17C83251-267A-4248-81A2-69C1072FFEFCQ38763898-EB9D7927-F6D1-4384-BD08-16F2CEFDB50CQ38842914-3D40CD57-3378-462E-8032-4FA16B7A18E3Q38911915-30F90078-224B-4756-9F9A-4C3B6BE012AEQ39412533-1E6435B4-CD2A-43D0-A0C8-CCC2290ECD30Q40687484-A9438C4F-606E-4F05-B573-67F38810BCC0Q41196210-0B3EFEA3-7539-48BA-9592-426A1EFDA52BQ41622450-C5FD530D-F753-4C4C-851F-9415B1657BEDQ41778753-1D6B70E7-AB29-4177-9A9E-44D076F314EAQ43236774-4A4B9C70-3665-4CC0-A0A3-FEB78DBC4E71Q47744875-0F281EF6-0005-42BC-BD21-DB6E682C678FQ47846250-C6148381-4DF1-4290-8A57-4444957E2380Q49164941-5295E6AA-4A42-491B-BA3E-9D67580170ABQ49836976-AB0B1DF1-328E-40B0-A912-B94B402DC72DQ52670774-C114D446-8ECF-4D03-AE95-493950ACD804Q54857519-74E31193-AF26-4A3C-A06E-48DC08950C32Q57805704-E1357C19-1B06-4639-A969-59C34B82797C
P2860
HLA-DQA1 and PLA2R1 polymorphisms and risk of idiopathic membranous nephropathy.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
HLA-DQA1 and PLA2R1 polymorphisms and risk of idiopathic membranous nephropathy.
@en
HLA-DQA1 and PLA2R1 polymorphisms and risk of idiopathic membranous nephropathy.
@nl
type
label
HLA-DQA1 and PLA2R1 polymorphisms and risk of idiopathic membranous nephropathy.
@en
HLA-DQA1 and PLA2R1 polymorphisms and risk of idiopathic membranous nephropathy.
@nl
prefLabel
HLA-DQA1 and PLA2R1 polymorphisms and risk of idiopathic membranous nephropathy.
@en
HLA-DQA1 and PLA2R1 polymorphisms and risk of idiopathic membranous nephropathy.
@nl
P2093
P2860
P50
P356
P1476
HLA-DQA1 and PLA2R1 polymorphisms and risk of idiopathic membranous nephropathy
@en
P2093
Artur Oliver
Gemma Bullich
José Ballarín
Montserrat M Díaz-Encarnación
Nadia Ayasreh
Sheila Santín
P2860
P304
P356
10.2215/CJN.05310513
P577
2013-11-21T00:00:00Z